- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 125,590 | 09.07.24 20:50:53 | -0,190 | -0,15% | 125,580 | 125,600 | 126,800 | 125,780 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 90,680 | 09.07.24 20:50:08 | +3,800 | +4,37% | 90,560 | 90,830 | 87,780 | 86,880 |
